Biotech News

Exagen Inc. to Participate in Upcoming Investor Conference

Exagen (XGN)Exagen2026-07-28 13:00 ESTConference / presentation

CARLSBAD, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today announced that management will participate in the following investor conference: Canaccord Genuity 46 th Annual Growth Conference – Boston, MA Date: August 11, 2026

Related news

XGNExagen2026-10-29 13:00 EST

Exagen Inc. to Participate in Upcoming Investor Conferences

CLDXCelldex Therapeutics2026-09-08 20:01 EST

Celldex to Present at Upcoming Investor Conference

GPCRStructure Therapeutics2026-11-04 12:30 EST

Structure Therapeutics to Participate in the Jefferies Global Healthcare Conference

SABSSAB Biotherapeutics2026-10-14 12:30 EST

SAB BIO to Participate in Chardan 10th Annual Healthcare Conference

BRLIBio-Reference Laboratories2026-09-08 17:55 EST

OPKO Health to Participate in the Wells Fargo 21st Annual Healthcare Conference

ZURAZura Bio2026-08-31 20:30 EST

Zura Bio to Participate in the Cantor Global Healthcare Conference

REGNRegeneron Pharmaceuticals2026-11-02 21:05 EST

Regeneron Announces Investor Conference Presentations

XFORX4 Pharmaceuticals2026-09-09 11:00 EST

X4 Pharmaceuticals to Participate in a Fireside Chat at the 2026 Wells Fargo Healthcare Conference

BIAFbioAffinity Technologies, Inc.2026-09-03 20:30 EST

bioAffinity Technologies to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

STTKShattuck Labs2026-10-13 12:00 EST

Shattuck Labs Announces Two Poster Presentations at UEG Week 2026

View all latest news

Exagen

Autoimmune Diagnostics Exagen provides diagnostic testing for autoimmune and rheumatic diseases. Its tests are designed to help clinicians resolve diagnostically complex cases and support ongoing disease management. AVISE CTD AVISE CTD is the company's flagship testing service for lupus and other connective-tissue diseases. It combines...

Recent company news

XGNExagen2026-10-29 13:00 EST

Exagen Inc. to Participate in Upcoming Investor Conferences

XGNExagen2026-10-27 13:00 EST

Exagen to Announce Third Quarter Financial Results on November 10, 2026

XGNExagen2026-08-04 12:00 EST

Exagen Inc. Reports Second Quarter 2026 Financial Results

XGNExagen2026-07-28 13:00 EST

Exagen Inc. to Participate in Upcoming Investor Conference

XGNExagen2026-07-21 13:00 EST

Exagen to Announce Second Quarter Financial Results on August 4, 2026

Stock data

Close: 7.60 USD
Market cap: 116.45M USD
Exchange: NASDAQ
Sector: MedTech
Location: United States